Phospholipid metabolism in cholesterol-loaded macrophages

Current Opinion in Lipidology

Volumn 8, Issue 5, 1997, Pages 263-267

  Tabas, Ira ^a  

^a Columbia University ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLESTEROL; CHOLESTEROL ESTER; CHOLINE PHOSPHATE CYTIDYLYLTRANSFERASE; PHOSPHATIDYLCHOLINE; PHOSPHOLIPID;

ATHEROSCLEROTIC PLAQUE; CELL DEATH; ENZYME ACTIVATION; MACROPHAGE; PHOSPHOLIPID METABOLISM; PHOSPHOLIPID SYNTHESIS; PRIORITY JOURNAL; SHORT SURVEY;

EID: 0030775933     PISSN: 09579672     EISSN: None     Source Type: Journal    
DOI: 10.1097/00041433-199710000-00004     Document Type: Short Survey

References (32)

1. St. Clair RW: Metabolism of the arterial wall and atherosclerosis. Atheroscler Rev 1976, 1:61-117.
2. Shio H, Haley NJ, Fowler S: Characterization of lipid-laden aortic cells from cholesterol-fed rabbits. II. Morphometric analysis of lipid-filled lysosomes and lipid droplets in aortic cell populations. Lab Invest 1978, 39:390-397.
3. Ross R: The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature 1993, 362:801-809.
4. Tabas I: The stimulation of the cholesterol esterification pathway by atherogenic lipoproteins in macrophages. Curr Opin Lipidol 1995, 6:260-268.
5. Shiratori Y, Okwu AK, Tabas I: Free cholesterol loading of macrophages stimulates phosphatidylcholine biosynthesis and up-regulation of CTP: phosphocholine cytidylyltransferase. J Biol Chem 1994, 269:11337-11348.
6. Tabas I, Marathe S, Keesler GA, Beatini N, Shiratori Y: Evidence that the Initial up-regulation of phosphatidylcholine biosynthesis in free cholesterol-loaded macrophages is an adaptive response that prevents cholesterol-induced cellular necrosis. Proposed role of an eventual failure of this response in foam cell necrosis in advanced atherosclerosis. J Biol Chem 1996, 271:22773-22781. This article presents the first evidence that the increase in PC biosynthesis in FC loaded macrophages helps prevent FC-mediated cytotoxicity. The strongest data are those in which blunting of the PC response is shown to cause a rise in the cellular FC:PL ratio and then cellular necrosis.
7. Katz SS, Shipley GG, Small DM: Physical chemistry of the lipids of human atherosclerotic lesions. Demonstration of a lesion intermediate between fatty streaks and advanced plaques. J Clin Invest 1976, 58:200-211.
8. Lundberg B: Chemical composition and physical state of lipid deposits in atherosclerosis. Atherosclerosis 1985, 56:93-110.
9. Small DM, Bond MG, Waugh D, Prack M, Sawyer JK: Physicochemical and histological changes in the arterial wall of nonhuman primates during progression and regression of atherosclerosis. J Clin Invest 1984, 73:1590-1605.
10. Rapp JH, Connor WE, Lin DS, Inahara T, Porter JM: Lipids of human atherosclerotic plaques and xanthomas: clues to the mechanism of plaque progression. J Lipid Res 1983, 24:1329-1335.
11. Shio H, Haley NJ, Fowler S: Characterization of lipid-laden aortic cells from cholesterol-fed rabbits. III. Intracellular localization of cholesterol and cholesteryl ester. Lab Invest 1979, 41:160-167.
12. Tangirala RK, Mahlberg FH, Glick JM, Jerome WG, Rothblat GH: Lysosomal accumulation of unesterified cholesterol in model macrophage foam cells. J Biol Chem 1993, 268:9653-9660.
13. Tabas I: Free cholesterol-induced cytotoxicity. A possible contributing factor to macrophage foam cell necrosis in advanced atherosclerotic lesions. Trends Cardiovasc Med 1997 (in press).
14. Yeagle PL: Modulation of membrane function by cholesterol. Biochimie 1991, 73:1303-1310.
15. Small DM: Progression and regression of atherosclerotic lesions. Arteriosclerosis 1988, 8:103-129.
16. Schmitz G, Beuck M, Fischer H, Nowicka G, Robenek H: Regulation of phospholipid biosynthesis during cholesterol influx and high density lipoprotein-mediated cholesterol efflux in macrophages. J Lipid Res 1990, 31:1741-1752.
17. Shiratori Y, Houweling M, Zha X, Tabas I: Stimulation of CTP: phosphocholine cytidylyltransferase by free cholesterol loading of macrophages involves signalling through protein dephosphorylation. J Biol Chem 1995, 270:29894-29903.
18. Jerome WG, Lewis JC: Early atherogenesis in White Carneau pigeons. II. Ultrastructural and cytochemical observations. Am J Pathol 1985, 119:210-222.
19. McGookey DJ, Anderson RGW: Morphological characterization of the cholesteryl ester cycle in cultured mouse macrophage foam cells. J Cell Biol 1983, 97:1156-1168.
20. Vance DE: Phosphatidylcholine metabolism: masochistic enzymology, metabolic regulation, and lipoprotein assembly. Biochem Cell Biol 1990, 68:1151-1165.
21. Kent C: Regulation of phosphatidylcholine biosynthesis. Prog Lipid Res 1991, 29:87-105.
22. Wang Y, Sweitzer TD, Weinhold PA, Kent C: Nuclear localization of soluble CTP: phosphocholine cytidylyltransferase. J Biol Chem 1993, 268:5899-5904.
23. Liscum L, Faust JR: The intracellular transport of low density lipoprotein-derived cholesterol is inhibited in Chinese hamster ovary cells cultured with 3-b-[2-(diethylamino)ethoxy]androst-5-en-17-one. J Biol Chem 1989, 264:11796-11806.
24. Mitchinson MJ, Hardwick SJ, Bennett MR: Cell death in atherosclerotic plaques. Curr Opin Lipidol 1996, 7:324-329. An excellent review on necrosis and apoptosis of cells in atherosclerotic lesions.
25. Guyton JR, Klemp KF: Development of the lipid-rich core in human atherosclerosis. Arterioscler Thromb Vasc Biol 1996, 16:4-11. An excellent review on the factors that lead to the accumulation of intracellular and extracellular lipids in early and advanced atherosclerotic lesions.
26. Heinle H: Metabolite concentration gradients in the arterial wall of experimental atherosclerosis. Exp Mol Pathol 1987, 46:312-320.
27. Libby P, Clinton SK: The role of macrophages in atherogenesis. Curr Opin Lipidol 1993, 4:355-363.
28. Fuster V, Badimon L, Badimon JJ, Chesebro JH: The pathogenesis of coronary artery disease and the acute coronary syndromes. N Engl J Med 1992, 326:242-250.
29. Brown MS, Goldstein JL: Lipoprotein metabolism in the macrophage: implications for cholesterol deposition in atherosclerosis. Annu Rev Biochem 1983, 52:223-261.
30. Schlechter I, Fogelman AM, Haberland ME, Seager J, Hokom M, Edwards PA: The metabolism of native and malondialdehyde-altered low density lipoproteins by human monocyte-macrophages. J Lipid Res 1981, 22:63-71.
31. Arias-Diaz J, Vara E, Garcia C, Balibrea JL: Tumor necrosis factor-α-induced inhibition of phosphatidylcholine synthesis by human type II pneumocytes is partially mediated by prostaglandins. J Clin Invest 1994, 94:244-250.
32. Breslow JL: Mouse models of atherosclerosis. Science 1996, 272:685-688. An excellent review of the currently available induced mutant mouse models in which human-like atherosclerotic lesions develop.